{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000514","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.911014+00:00","generated_at":"2026-05-24T05:56:09.310137+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lucid Diagnostics reports Q4 EsoGuard revenue $1.2M, record 4,042 tests processed","bullets":["Record 4,042 EsoGuard tests processed in Q4 2024, up 45% sequentially and 84% year-over-year.","EsoGuard revenue of $1.2M for Q4; GAAP net loss $11.5M ($0.20/share); non-GAAP loss $10.9M ($0.19/share).","Cash and equivalents $22.4M at Dec 31, 2024; pro forma ~$36.9M after Q1 2025 common stock financing.","Secured first commercial coverage from Highmark and first state biomarker agreement with Blue Cross Blue Shield of RI.","Completed $22M convertible debt refinancing and $15.3M stock financing, net proceeds $32.8M, extending cash runway."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000514","json":"https://secwatch.observer/filing/0001641172-25-000514.json","markdown":"https://secwatch.observer/filing/0001641172-25-000514.md","text":"https://secwatch.observer/filing/0001641172-25-000514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225000514/0001641172-25-000514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000164117225000514/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:56:09.310137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}